Aspyrian Therapeutics Obtains $15,199,998 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bf55d636-dc16-42ff-88df-8beb589df976 - Date
10/6/2016 - Company Name
Aspyrian Therapeutics - Mailing Address
10575 Roselle Street San Diego, CA 92121 USA - Company Description
Developing the next generation of targeted therapies for oncology. - Website
http://www.aspyriantherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$15,199,998 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
